Following Roland's Cosmetic Clinic Closure... Director Mikihiko Takasu Criticizes the Rise of Certain Cosmetic Clinics as "Ignoramus Business" - Sirabee

SUMMARY

According to Google News reports on clinic closures, "Following Roland's Cosmetic Clinic Closure... Director Mikihiko Takasu Criticizes the Rise of Certain Cosmetic Clinics as 'Ignoramus Business' - Sirabee" has been reported. This information is relevant for management decisions concerning hospitals, clinics, and medical corporations, serving as insights into the latest trends in the medical industry.

📝 EDITOR'S NOTE — A Medical M&A Perspective

While the news of Roland's cosmetic clinic closure might initially seem like a mere business decision by an individual proprietor, it highlights a dual challenge: the difficulty of business succession in the medical industry, particularly in the aesthetic medicine sector, and the underlying concern about the proliferation of "ignoramus businesses."

The "ignoramus business" pointed out by Director Mikihiko Takasu likely refers to clinics that exploit informationally disadvantaged individuals, pushing unnecessary procedures or expensive contracts. Such clinics often lack a sustainable business foundation and tend to focus solely on short-term profit. Consequently, they risk facing management difficulties and sudden closures, as seen in Roland's case. This attitude may also be shared by medical institution managers who opt for an easy closure without considering business succession due to a lack of successors.

In the context of medical M&A and business succession, this news serves as a reminder of the opportunity cost associated with choosing closure and the importance of sound succession planning. Closure entails ceasing services to patients, job losses for staff, and potentially costs for restoration. Conversely, appropriate third-party succession holds the potential to carry over the brand and expertise, continue contributing to regional healthcare, and maintain staff employment.

For owners and successors of aesthetic medicine clinics facing succession issues, it is crucial to self-reflect on whether their own clinic risks falling into the "ignoramus business" model and whether concrete business succession options have been considered in preparation for unforeseen circumstances. To ensure sustainable management and fulfill responsibilities to patients, early consultation regarding business succession should be considered before resorting to closure as a final option.

News Highlights

In response to the closure of Roland’s cosmetic clinic, Director Mikihiko Takasu is sounding the alarm about the increase in certain cosmetic clinics, which he terms an “ignoramus business.” The news highlights suggest that while clinic closure costs can run into millions of yen, business succession typically aims for a valuation of 0.5 to 1.5 times annual sales. It also notes that the succession period for clinics without inpatient facilities is often completed within 4 to 10 months, and that consultations before closure can potentially allow for the continuation of staff employment and patient care.

M&A Medical Editorial Department’s Perspective

The fact that Director Takasu uses the symbolic closure of Roland’s cosmetic clinic as a hook to address the rise of certain cosmetic clinics, which he criticizes as an “ignoramus business,” cannot be overlooked from the perspective of sound management and patient protection in the cosmetic medicine industry. In particular, the figures indicating that while closure incurs costs of several million yen, business succession can potentially yield a valuation of 0.5 to 1.5 times annual sales, concretely suggest the economic benefits of succession for business owners. The realistic timeframe of 4 to 10 months for the completion of succession for clinics without inpatient facilities also underscores the importance of early consideration. By choosing succession over closure, the possibility of fulfilling social responsibilities that the industry as a whole should prioritize, such as continuing staff employment and patient care, increases, making this perspective extremely important for business owners.

Points Raised by This News

Roland’s clinic closure triggers criticism of “ignoramus business,” raising concerns about the health of the cosmetic clinic industry.
A financial comparison between closure costs (millions of yen) and business succession valuation (0.5-1.5 times annual sales) concretely presents the benefits of succession.
Since the succession period for clinics without inpatient facilities is a realistic 4-10 months, early consideration of business succession is effective.
Consultations before closure suggest the possibility of balancing the continuation of staff employment and patient care.

Practical Questions Arising from This News

What specific methods are used by cosmetic clinics criticized as “ignoramus businesses” for patient acquisition and operation?
Is the closure of Roland’s clinic an isolated incident, or a sign of industry-wide trends in M&A and business succession?
What specific financial indicators or conditions serve as criteria for deciding whether to choose closure or business succession?

If You Feel “Should I Consult Too?”

Business owners who feel concerned about their clinic’s future or the industry’s health upon hearing the term “ignoramus business” should first concretely consider the option of business succession. Closure can involve costs of several million yen and potential opportunity losses exceeding that amount. The valuation for business succession, ranging from 0.5 to 1.5 times annual sales, can represent a return significantly exceeding closure costs. Considering the possibility of succession completion within 4 to 10 months, early consultation with experts is essential to achieve a smooth business succession while minimizing the impact on staff and patients.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a complete success fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are accepted with strict confidentiality. Free consultations here

📌 Source (Primary Information)

Following Roland’s Cosmetic Clinic Closure… Director Mikihiko Takasu Criticizes the Rise of Certain Cosmetic Clinics as “Ignoramus Business” – Sirabee

Source: Google News: Clinic Closures

Please see the original article for details

Regarding trends in medical institutions like this case,

we provide a detailed explanation of the 'Medical Succession Guide'

Read the Complete Guide →